🌍 Regional Context
❌ Unlike global #IMPower150 (which showed significant PFS/OS benefits), #IMPower151 highlights differences in Asian vs. Western populations: 53% had #EGFR mutations (vs. 14% in IMP150) and 97% used pemetrexed (vs. paclitaxel in IMP150).
#Onco404 #Cancer #Kanser #MedSky #OncSky
0
0
1
0